Alcohol Use in HIV/AIDS: Compounded Immune Suppression and Infection Risk

Mechanistic Synergy

  • HIV depletes CD4+ T cells → impaired cellular immunity.
  • Alcohol suppresses:
    • Neutrophil chemotaxis/phagocytosis
    • Macrophage TNF-α, IL-1 production
    • NK cell cytotoxicity
    • Dendritic cell antigen presentation
    • Mucosal barrier integrity (gut → microbial translocation → systemic LPS → chronic immune activation)

Clinical Consequences

  • Opportunistic Infections: PJP, TB, MAC, cryptococcal meningitis, CMV — higher incidence, atypical presentation, worse outcomes.
  • ART Adherence: Alcohol → missed doses → resistance → virologic failure.
  • Liver Disease: HCV/HBV coinfection + alcohol + ART hepatotoxicity → accelerated fibrosis.
  • Cancer: HPV-related (anal, cervical, oropharyngeal) — alcohol + immune dysfunction = persistence/progression.

Guidance

Abstinence ideal. If not achievable, harm reduction: <14 drinks/week (men), <7 (women); screen AUDIT-C; treat AUD (naltrexone, acamprosate, gabapentin) within HIV care.

HIV & AIDS - Related Articles